The outcomes of conservative and surgical treatment of stage 2 bisphosphonate-related osteonecrosis of the jaws: a case series

Russell, 2007, Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy, Ann N Y Acad Sci, 1117, 209, 10.1196/annals.1402.089

Bellido, 2011, Novel actions of bisphosphonates in bone: preservation of osteoblast and osteocyte viability, Bone, 49, 50, 10.1016/j.bone.2010.08.008

Cornish, 2011, Bone-bound bisphosphonate inhibits growth of adjacent non-bone cells, Bone, 49, 710, 10.1016/j.bone.2011.07.020

Delmas, 2005, The use of bisphosphonates in the treatment of osteoporosis, Curr Opin Rheumatol, 17, 462

Siris, 1997, Management of Paget's disease of bone in the era of new and more potent bisphosphonates, Endocr Pract, 3, 264, 10.4158/EP.3.4.264

Giordano, 2008, Use of intravenous bisphosphonates in older women with breast cancer, Oncologist, 13, 494, 10.1634/theoncologist.2007-0200

Saad, 2010, Guidelines for the management of castrate-resistant prostate cancer, Can Urol Assoc J, 4, 380, 10.5489/cuaj.10167

McKeage, 2008, Zoledronic acid: a pharmacoeconomic review of its use in the management of bone metastases, Pharmacoeconomics, 26, 251, 10.2165/00019053-200826030-00007

Santini, 2003, The antineoplastic role of bisphosphonates: from basic research to clinical evidence, Ann Oncol, 14, 1468, 10.1093/annonc/mdg401

Sun, 2010, The crossover of bisphosphonates to cancer therapy, Ann N Y Acad Sci, 1211, 107, 10.1111/j.1749-6632.2010.05812.x

Khosla, 2007, Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research, J Bone Miner Res, 22, 1479, 10.1359/jbmr.0707onj

Ruggiero, 2009, American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws—2009 update, J Oral Maxillofac Surg, 67, 2, 10.1016/j.joms.2009.01.009

Lo, 2010, Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure, J Oral Maxillofac Surg, 68, 243, 10.1016/j.joms.2009.03.050

Ruggiero, 2004, Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases, J Oral Maxillofac Surg, 62, 527, 10.1016/j.joms.2004.02.004

Carlson, 2009, The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws, J Oral Maxillofac Surg, 67, 85, 10.1016/j.joms.2009.01.006

Curi, 2011, Bisphosphonate-related osteonecrosis of the jaws—an initial case series report of treatment combining partial bone resection and autologous platelet-rich plasma, J Oral Maxillofac Surg, 69, 2465, 10.1016/j.joms.2011.02.078

Stanton, 2009, Outcome of surgical management of bisphosphonate-related osteonecrosis of the jaws: review of 33 surgical cases, J Oral Maxillofac Surg, 67, 943, 10.1016/j.joms.2008.12.057

Williamson, 2010, Surgical management of bisphosphonate induced osteonecrosis of the jaws, Int J Oral Maxillofac Surg, 39, 251, 10.1016/j.ijom.2009.11.014

Allen, 2011, Bisphosphonate effects on bone turnover, microdamage, and mechanical properties: what we think we know and what we know that we don’t know, Bone, 49, 56, 10.1016/j.bone.2010.10.159

Corso, 2007, A different schedule of zoledronic acid can reduce the risk of the osteonecrosis of the jaw in patients with multiple myeloma, Leukemia, 21, 1545, 10.1038/sj.leu.2404682

Manfredi, 2011, Bisphosphonate-related osteonecrosis of the jaws: a case series of 25 patients affected by osteoporosis, Int J Oral Maxillofac Surg, 40, 277, 10.1016/j.ijom.2010.11.002

Migliorati, 2003, Bisphosphanates and oral cavity avascular bone necrosis, J Clin Oncol, 21, 4253, 10.1200/JCO.2003.99.132

Salesi, 2006, Bisphosphonates and oral cavity avascular bone necrosis: a review of twelve cases, Anticancer Res, 26, 3111

Wang, 2003, Osteonecrosis of the jaws associated with cancer chemotherapy, J Oral Maxillofac Surg, 61, 1104, 10.1016/S0278-2391(03)00328-8

Lipton, 2011, Denosumab: benefits of RANK ligand inhibition in cancer patients, Curr Opin Support Palliat Care, 5, 258, 10.1097/SPC.0b013e328349731c

Reid, 2011, Epidemiology and pathogenesis of osteonecrosis of the jaw, Nat Rev Rheumatol, 8, 90, 10.1038/nrrheum.2011.181

Taylor, 2010, Osteonecrosis of the jaws induced by anti-RANK ligand therapy, Br J Oral Maxillofac Surg, 48, 221, 10.1016/j.bjoms.2009.08.030

Amin Kerachian, 2010, New insights into the pathogenesis of glucocorticoid-induced avascular necrosis: microarray analysis of gene expression in a rat model, Arthritis Res Ther, 12, R124, 10.1186/ar3062

Urbaniak, 1998, Revascularization of the femoral head in osteonecrosis, J Am Acad Orthop Surg, 6, 44, 10.5435/00124635-199801000-00005

Lodi, 2010, Tooth extraction in patients taking intravenous bisphosphonates: a preventive protocol and case series, J Oral Maxillofac Surg, 68, 107, 10.1016/j.joms.2009.07.068

Ferlito, 2011, Preventive protocol for tooth extractions in patients treated with zoledronate: a case series, J Oral Maxillofac Surg, 69, e1, 10.1016/j.joms.2010.10.055

Schwartz, 2005, Bisphosphonate-associated osteonecrosis of the jaws, J Oral Maxillofac Surg, 63, 1555, 10.1016/j.joms.2005.06.003